Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Sep 12;8:13953. doi: 10.1038/s41598-018-31455-w

Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease

Shuchun Chen 1,2, Seong-Jin Yu 1, Yazhou Li 3, Daniela Lecca 3, Elliot Glotfelty 3, Hee Kyung Kim 4, Ho-Il Choi 4, Barry J Hoffer 5, Nigel H Greig 3,, Dong Seok Kim 3,4, Yun Wang 1,
PMCID: PMC6135809  PMID: 30209317

Correction to: Scientific Reports 10.1038/s41598-018-28449-z, published online 16 July 2018

The original version of this Article contained a typographical error in the spelling of the author Dong Seok Kim, which was incorrectly given as Dong-Seok Kim. This has now been corrected in the PDF and HTML versions of the Article, and in the accompanying Supplementary Information file.

Contributor Information

Nigel H. Greig, Email: Greign@mail.nih.gov

Yun Wang, Email: ywang@nhri.org.tw.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES